Results 61 to 70 of about 30,790 (243)

Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies [PDF]

open access: yes, 2010
Sequence variants at the TERT-CLPTM1L locus in chromosome 5p have been recently associated with disposition for various cancers. Here we show that this locus including the gene encoding the telomerase reverse-transcriptase TERT at 5p13.33 is rarely but ...
Akasaka, T. (T.)   +16 more
core  

Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma [PDF]

open access: yes, 2016
Key Points Combining phosphatidylinositol-3-kinase δ inhibition with rituximab, bendamustine, or both is feasible and active in relapsed iNHL.
Barrientos, Jacqueline C.   +14 more
core   +2 more sources

Family history of haematological malignancy and prognosis across non‐Hodgkin lymphoma subtypes

open access: yesBritish Journal of Haematology, EarlyView.
Multivariable‐adjusted associations between family history of haematological malignancy (FHHM) and survival outcomes by non‐Hodgkin lymphoma subtype [OS (A), EFS (B), LSS (C) and failure to achieve EFS at 24 months (D)]. Subtype‐specific analyses showed that FHHM was associated with significantly inferior EFS in MCL and inferior LSS in FL.
George A. Cholack   +16 more
wiley   +1 more source

A case of primary cutaneous marginal zone B-cell lymphoma

open access: yesPifu-xingbing zhenliaoxue zazhi
We report a case of primary cutaneous marginal zone B-cell lymphoma. A 23-year-old male presented with red nodules on his back for 5 years. Physical examination revealed multiple demarcated red nodules on the back, sized 5 mm×5 mm to 10 mm×15 mm, with ...
HUANG Jiamin, SUN Zhaojun, REN Haiyue
doaj   +1 more source

Infectious aetiology of marginal zone lymphoma and role of anti-infective therapy [PDF]

open access: yes, 2016
Marginal zone lymphomas have been associated with several infectious agents covering both viral and bacterial pathogens and in some cases a clear aetiological role has been established.
Annechini, Giorgia   +3 more
core   +1 more source

Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia

open access: yesHaematologica, 2008
Background Low-grade B-cell lymphomas are a very heterogeneous group of tumors, whose differential diagnosis is frequently compromised by the lack of specific cytogenetic or molecular features.
Bibiana I. Ferreira   +8 more
doaj   +1 more source

Diagnostic performance of the microRNA‐371a assay in small testicular masses: a real‐world cohort study

open access: yesBJU International, EarlyView.
Objectives To evaluate the diagnostic performance of the Conformité Européenne [CE]‐certified microRNA‐371a‐3p (miR371a) assay in patients undergoing inguinal exploration for small testicular masses of unknown histology in a real‐world setting. Patients and Methods Between March 2023 and March 2024, 60 patients underwent inguinal exploration for ...
Felix Seelemeyer   +6 more
wiley   +1 more source

Primary Pulmonary Anaplastic Large Cell Lymphoma: A Rare Malignancy and Rare Cause of the Luftsichel Sign

open access: yesCase Reports in Radiology, 2018
Primary pulmonary lymphomas are rare with primary pulmonary non-Hodgkin lymphoma accounting for only 0.3% of primary lung neoplasms. Of these, the large majority are made up of marginal zone B-cell lymphoma and diffuse large B-cell lymphoma. We present a
Elizabeth Von Ende   +3 more
doaj   +1 more source

Tafasitamab as Monotherapy or in Combination in Japanese Patients With B‐Cell Non‐Hodgkin Lymphoma: Results From the Phase 1b J‐MIND Study

open access: yesCancer Science, EarlyView.
J‐MIND evaluated the safety and tolerability of tafasitamab, a CD19‐targeting monoclonal antibody, alone or in combination with other therapies in Japanese patients with B‐cell non‐Hodgkin lymphoma (NHL). Most common treatment‐emergent adverse events across all groups were hematological, and no serious tafasitamab treatment‐related or fatal adverse ...
Koji Izutsu   +7 more
wiley   +1 more source

Presenting Clinical Features of Vitreoretinal Lymphoma

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Vitreoretinal lymphoma is a rare cancer, widely recognised to present diagnostic challenges. We aimed to report information that would support the clinician in considering this diagnosis. Methods We interrogated the International Vitreoretinal B‐Cell Lymphoma Registry for clinical data from patients newly diagnosed with ...
The International Vitreoretinal B‐Cell Lymphoma Registry Investigator Group   +64 more
wiley   +1 more source

Home - About - Disclaimer - Privacy